Cluster #2 showed significant or trend reductions in G-CSF, IL-8, IL-15, and IL-2, and increases in IL-1β, eotaxin, and MIP-1α in the MCI/AD serum but no significant or trend-wise parallel alterations in the CSF. This evidence concerns the gene CSF3 and Alzheimer disease.